2008Journal of Henan Medical College for Staff and WorkersRequires access

Bioequivalence of Sparfloxacin Enteric Capsules Vervus Tablets

MA Xiang-qin

Open publisher page 0 citations

Abstract

Objective To evaluate the bioequivalence of Sparfloxacin tables.Methods Eighteen healthy volunteers were randomly administrated with an oral single and crossover dose of Sparfloxacin tablets 400 mg each.The serum concentration of Sparfloxacin was measured by HPLC.The pharmacokinetics parameters were calculated using 3P97 practical pharmacokinetics program. Results The pharmacokinetic parameters of Sparfloxacin,two kinds of tables were as the following: t1/2(15.09±2.31) vs.(14.34±1.93)h,Cmax(1.93±0.07)vs.(1.90±0.07) mg/L,Tmax(3.17±0.38) vs.(3.17±0.38)h,AUC0-12h(36.93±4.44)vs.(38.23±4.43)mg.h/L,AUC0-∞(39.48±4.58) vs.(40.61±4.46)mg.h/L.The relative bioavailability of Sparfloxacin,two kinds of tables were(96.6±4.2)%vs.(97.2±4.0)%.Conclusion Sparfloxacin,two kinds of tables are bioequivalent.

About this research paper

What this paper is about

Objective To evaluate the bioequivalence of Sparfloxacin tables.Methods Eighteen healthy volunteers were randomly administrated with an oral single and crossover dose of Sparfloxacin tablets 400 mg each.The serum concentration of Sparfloxacin was measured by HPLC.The pharmacokinetics parameters were calculated using 3P97 practical pharmacokinetics program. Results The pharmacokinetic parameters of Sparfloxacin,two kinds of tables were as the following: t1/2(15.09±2.31) vs.(14.34±1.93)h,Cmax(1.93±0.07)vs.(1.90±0.07) mg/L,Tmax(3.17±0.38) vs.(3.17±0.38)h,AUC0-12h(36.93±4.44)vs.(38.23±4.43)mg.h/L,AUC0-∞(39.48±4.58) vs.(40.61±4.46)mg.h/L.The relative bioavailability of Sparfloxacin,two kinds of tables were(96.6±4.2)%vs.(97.2±4.0)%.Conclusion Sparfloxacin,two kinds of tables are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the bioequivalence of Sparfloxacin tables.Methods Eighteen healthy volunteers were randomly administrated with an oral single and crossover dose of Sparfloxacin tablets 400 mg each.The serum concentration of Sparfloxacin was measured by HPLC.The pharmacokinetics parameters were calculated using 3P97 practical pharmacokinetics program. Results The pharmacokinetic parameters of Sparfloxacin,two kinds of tables were as the following: t1/2(15.09±2.31) vs.(14.34±1.93)h,Cmax(1.93±0.07)vs.(1.90±0.07) mg/L,Tmax(3.17±0.38) vs.(3.17±0.38)h,AUC0-12h(36.93±4.44)vs.(38.23±4.43)mg.h/L,AUC0-∞(39.48±4.58) vs.(40.61±4.46)mg.h/L.The relative bioavailability of Sparfloxacin,two kinds of tables were(96.6±4.2)%vs.(97.2±4.0)%.Conclusion Sparfloxacin,two kinds of tables are bioequivalent.

Key concepts: Sparfloxacin, Bioequivalence, Pharmacokinetics, Bioavailability, Cmax, Pharmacology, Medicine, High-performance liquid chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of Sparfloxacin Enteric Capsules Vervus Tablets — Research Paper | ScholarLens